Detalhe da pesquisa
1.
Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.
Blood Adv
; 3(20): 2920-2933, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648314